Skip to main content
. Author manuscript; available in PMC: 2008 Nov 25.
Published in final edited form as: Med Care. 2006 Jun;44(6):506–512. doi: 10.1097/01.mlr.0000215890.30756.b2

Table 4.

Acute phase episode analyses

Frequency of outcomes measures
Pre Parity (N=1,753) Post Parity (N=2,255) Percentage point change
Outcome measure N % N % %
Duration of follow-up (MH/SA visits and/or antidepressants) ≥ 4 months 909 51.9 1,335 59.2 +7.3
Intensity of follow-up (i.e., any MH/SA visit) 1st 2 months ≥ 2 per month 451 25.7 635 28.2 +2.5
Intensity of follow-up (i.e., any MH/SA visit) 2nd 2 months ≥ 1 per month 533 30.4 723 32.1 +1.7
    Conditional on any psychotherapy, duration ≥3 months^ 519 56.8 743 59.0 +2.2
    Conditional on any psychotherapy, intensity ≥2 per month^ 278 30.4 344 27.3 −3.1
    Conditional on any antidepressant, duration at least 3 months^ 363 56.7 459 58.6 +1.9
^ Percentages based on subset of population receiving the specific treatment.
Logistic regression results. Log-odds and odds ratio of receiving care post-parity, adjusting for baseline characteristics.
Outcome measure β s.e. Z score OR CI
Duration of follow-up (MH/SA visits and/or antidepressants) ≥ 4 months 0.316 0.067 4.72* 1.37 1.20−1.56
Intensity of follow-up (i.e., any MH/SA visit) 1st 2 months ≥ 2 per month 0.088 0.069 1.27 1.09 0.95−1.25
Intensity of follow-up (i.e., any MH/SA visit) 2nd 2 months ≥ 1 per month 0.048 0.068 0.70 1.05 0.92−1.20
    Conditional on any psychotherapy, duration ≥3 months 0.106 0.088 1.20 1.11 0.93−1.32
    Conditional on any psychotherapy, intensity ≥2 per month (-)0.144 0.093 (-)1.55 0.86 0.72−1.04
    Conditional on any antidepressant, duration at least 3 months 0.020 0.109 0.18 1.02 0.82−1.26
*

p. value <0.0001